Clinical Trial Detail

NCT ID NCT03427814
Title Study of BGB-290 or Placebo in Patients With Advanced or Inoperable Gastric Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors BeiGene
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Pamiparib

Age Groups: adult senior

No variant requirements are available.